ERCC1 and neoplasm: Several studies have shown that high ERCC1 expression is a good prognostic factor in patients without cisplatin-based chemotherapy and also a predictor for poor clinical outcome in patients with cisplatin-based chemotherapy for various tumor types [12,14,15,18].